Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing

被引:223
|
作者
Zhang, Song [1 ]
Shen, Jiangtao [2 ]
Li, Dali [3 ]
Cheng, Yiyun [1 ,3 ]
机构
[1] South China Univ Technol, Sch Mol Sci & Engn, South China Adv Inst Soft Matter Sci & Technol, Guangzhou 510640, Peoples R China
[2] Yangzhou Univ, Peoples Hosp Taizhou 2, Taizhou 225500, Peoples R China
[3] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China
来源
THERANOSTICS | 2021年 / 11卷 / 02期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
genome editing; CRISPR; RNP; polymers; nanoparticles; SPHERICAL NUCLEIC-ACIDS; BLACK PHOSPHORUS NANOSHEETS; HOMOLOGY-DIRECTED REPAIR; EFFICIENT DELIVERY; PROTEIN DELIVERY; IN-VITRO; EXTRACELLULAR VESICLES; NANOPARTICLE DELIVERY; INTRACELLULAR PROTEIN; MEDIATED DELIVERY;
D O I
10.7150/thno.47007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CRISPR/Cas9 genome editing has gained rapidly increasing attentions in recent years, however, the translation of this biotechnology into therapy has been hindered by efficient delivery of CRISPR/Cas9 materials into target cells. Direct delivery of CRISPR/Cas9 system as a ribonucleoprotein (RNP) complex consisting of Cas9 protein and single guide RNA (sgRNA) has emerged as a powerful and widespread method for genome editing due to its advantages of transient genome editing and reduced off-target effects. In this review, we summarized the current Cas9 RNP delivery systems including physical approaches and synthetic carriers. The mechanisms and beneficial roles of these strategies in intracellular Cas9 RNP delivery were reviewed. Examples in the development of stimuli-responsive and targeted carriers for RNP delivery are highlighted. Finally, the challenges of current Cas9 RNP delivery systems and perspectives in rational design of next generation materials for this promising field will be discussed.
引用
收藏
页码:614 / 648
页数:35
相关论文
共 50 条
  • [21] CRISPR/CAS9: THE GOLD STANDARD OF GENOME EDITING?
    Gleeson, Alfie
    Sawyer, Abigail
    [J]. BIOTECHNIQUES, 2018, 64 (06) : 239 - 244
  • [22] CRISPR/CAS9, the King of Genome Editing Tools
    Bannikov, A. V.
    Lavrov, A. V.
    [J]. MOLECULAR BIOLOGY, 2017, 51 (04) : 514 - 525
  • [23] Genome Editing in Cotton with the CRISPR/Cas9 System
    Gao, Wei
    Long, Lu
    Tian, Xinquan
    Xu, Fuchun
    Liu, Ji
    Singh, Prashant K.
    Botella, Jose R.
    Song, Chunpeng
    [J]. FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [24] CRISPR/Cas9 and other techniques for genome editing
    Hartung, Frank
    Schiemann, Jochen
    Sprink, Thorben
    [J]. ZWEITES SYMPOSIUM ZIERPFLANZENZUCHTUNG, 2017, 2017, 457 : 36 - 39
  • [25] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [26] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    [J]. Current Genetics, 2020, 66 : 447 - 462
  • [27] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    [J]. TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [28] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [29] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [30] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18